ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
84 hedge funds and large institutions have $65M invested in Oncternal Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
36% less call options, than puts
Call options by funds: $1.33M | Put options by funds: $2.08M
Holders
84
Holding in Top 10
–
Calls
$1.33M
Puts
$2.08M
Top Buyers
| 1 | +$10.1M | |
| 2 | +$3.38M | |
| 3 | +$2.4M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$2.35M |
| 5 |
Two Sigma Investments
New York
|
+$2.1M |
Top Sellers
| 1 | -$4.51M | |
| 2 | -$2.69M | |
| 3 | -$1.75M | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$1.73M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.32M |